General Biotechnology

In the relentless race to develop groundbreaking new medicines, the pharmaceutical industry often overlooks a powerful, underutilized strategy: drug repurposing. As highlighted in the recent Drug Patent Watch blog post, “No Patents, No Problem? The Unt…

In the high-stakes world of pharmaceutical innovation, the race to develop the next blockbuster drug is relentless. Yet, lurking beneath the surface of patent filings and R&D pipelines lies an often-overlooked goldmine: abandoned drug patents and u…

Unlocking Revenue Before the Patent Cliff: How Biopharma Equipment Suppliers Can Turn LOE Timelines into a Predictable Sales Pipeline
Imagine this: your biopharma company has just launched a groundbreaking drug, and the excitement is palpable. But lurk…

Unlocking the Hidden Power of Market Access Vendors: How Timing and Litigation Strategies Are Reshaping Pharma Success
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is more than just a matter of scientifi…

In the high-stakes world of pharmaceuticals, timing isn’t just everything — it’s the difference between success and obsolescence. As innovation accelerates and patent landscapes become increasingly complex, understanding the intricate dance of patent t…

Unlocking the Secrets of Successful Paragraph IV Challenges: Your Ultimate Due Diligence Playbook
In the high-stakes world of pharmaceutical patent litigation, the difference between a lucrative patent challenge and a costly misstep often hinges on one…

In the high-stakes world of pharmaceuticals, securing market exclusivity isn’t just about innovation—it’s about strategic legal maneuvers that can make or break a company’s bottom line. Yet, what if the very patents that grant exclusivity are vulnerabl…

Unlocking the Hidden Signals in Litigation Data: The Secret Weapon for Pharma Market Strategy
In the high-stakes world of pharmaceuticals, timing is everything. When a blockbuster drug’s patent expires, the race to launch a generic version can mean bil…

In the high-stakes world of pharmaceuticals, the race to innovate is only half the battle. The other half? Navigating the complex landscape of patent expirations, generic entry, and revenue erosion — all while safeguarding market share and maximizing p…

In the relentless race to innovate, the biopharmaceutical industry faces a daunting challenge: the impending "biopharma super-cliff." As patent protections expire and biosimilar competition looms, many industry leaders are grappling with decl…